tangeretin has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arab, HH; Arafa, el-SA; Mohamed, WR; Omar, HA | 1 |
| Chen, F; Ma, Y; Sun, Z; Zhu, X | 1 |
2 other study(ies) available for tangeretin and malondialdehyde
| Article | Year |
|---|---|
Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Chemical and Drug Induced Liver Injury; Cholesterol; Cisplatin; Flavones; Glutathione; Immunohistochemistry; Liver; Liver Function Tests; Male; Malondialdehyde; Mitogen-Activated Protein Kinases; Nitric Oxide; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Silymarin; Triglycerides | 2016 |
Tangeretin inhibits high glucose-induced extracellular matrix accumulation in human glomerular mesangial cells.
Topics: Cell Cycle; Cell Line; Cell Proliferation; Collagen Type IV; Enzyme Activation; Extracellular Matrix; Fibronectins; Flavones; Gene Expression Regulation; Glucose; Humans; Malondialdehyde; MAP Kinase Signaling System; Mesangial Cells; NADPH Oxidases; Reactive Oxygen Species; Superoxide Dismutase; Transforming Growth Factor beta1 | 2018 |